國家衛生研究院 NHRI:Item 3990099045/14952
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 925011      線上人數 : 942
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版
    國家衛生研究院 NHRI > 癌症研究所 > 其他 > 期刊論文 >  Item 3990099045/14952


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/14952


    題名: Ankylosing spondylitis shares a common therapeutic target with breast cancer
    作者: Feng, FY;Lee, WK;Chou, MC;Chu, PY;Lin, HY
    貢獻者: National Institute of Cancer Research
    摘要: We read with great interest the retrospective cohort study by Kelty el al on the association between cancer diagnosis and mortality in patients with ankylosing spondylitis (AS). Patients diagnosed with AS (n = 2152) and a non- AS comparison group (n = 10 760) were included. Document of cancer diagnosis, comorbidities and mortality were extracted from medical record. The relative risk and mortality subsequent to cancer diagnosis of AS and non- AS were analyzed. This study demonstrated that AS per se has no association with cancer risk, while AS presents an association with increased risk of 5-year mortality in patients previously diagnosed with cancer. With regard to the pathophysiology of AS, human leukocyte antigen (HLA)- B27 and interleukin (IL)- 23/−17 axis plays a central role in relaying proinflammatory response and is involved in the disease severity. In the context of AS, differentiated T cells act to secret high levels of IL- 17, which can further trigger proinflammatory response in coordination with tumor necrosis- α and interferon- γ and activate osteoclasts, leading to suppression of bone regeneration. Notably, 2 phase III studies showed that anti- IL- 17 by using secukinumab exerts salient efficacy on the improvement of signs, symptoms, physical activity and disease - specific quality of life.
    日期: 2023-08
    關聯: International Journal of Rheumatic Diseases. 2023 Aug;26(8):1633-1634.
    Link to: http://dx.doi.org/10.1111/1756-185x.14658
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1756-1841&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000944059200001
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85150391818
    顯示於類別:[其他] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    ISI000944059200001.pdf320KbAdobe PDF108檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋